XT
WST icon

XTX Topco’s West Pharmaceutical WST Stock Holding History

XTX Topco’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.69M Sell
4,697
-4,343
-48% -$1.33M 0.02% 1288
2026
Q1 		$2.27M Buy
9,040
+6,325
+233% +$1.57M 0.04% 733
2025
Q4 		$747K Buy
+2,715
New +$743K 0.02% 1256
2025
Q3 		– Sell
-2,095
Closed -$458K – 3379
2025
Q2 		$458K Sell
2,095
-8,822
-81% -$1.89M 0.02% 1163
2025
Q1 		$2.44M Buy
10,917
+9,750
+835% +$2.69M 0.13% 183
2024
Q4 		$382K Buy
1,167
+103
+10% +$32.4K 0.03% 1007
2024
Q3 		$319K Sell
1,064
-3,019
-74% -$925K 0.02% 1144
2024
Q2 		$1.34M Sell
4,083
-1,333
-25% -$471K 0.12% 257
2024
Q1 		$2.14M Buy
5,416
+4,348
+407% +$1.61M 0.29% 22
2023
Q4 		$376K Buy
+1,068
New +$378K 0.08% 452
2022
Q4 		– Sell
-1,618
Closed -$398K – 1556
2022
Q3 		$398K Buy
+1,618
New +$493K 0.1% 346
2022
Q2 		– Sell
-811
Closed -$333K – 1140
2022
Q1 		$333K Buy
+811
New +$317K 0.15% 236
2021
Q3 		– Sell
-4,194
Closed -$1.51M – 1104
2021
Q2 		$1.51M Buy
+4,194
New +$1.39M 0.51% 6

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

XTX Topco's WST Position: Q2 2026 in Review

XTX Topco reduced its West Pharmaceutical (WST) stake by 48% in Q2 2026, selling an estimated $1.33M and leaving 4,697 shares worth $1.69M. The position accounts for 0.02% of the portfolio, ranked #1288.

XTX Topco first reported a position in WST in Q2 2021 and has held it in 13 quarters since. The position peaked at $2.44M in Q1 2025. 830 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • XTX Topco held 4,697 shares of West Pharmaceutical worth $1.69M as of Q2 2026.
  • XTX Topco sold 4,343 West Pharmaceutical shares in Q2 2026, an estimated $1.33M.
  • West Pharmaceutical made up 0.02% of XTX Topco's portfolio in Q2 2026, its #1288 holding.
  • XTX Topco first reported a position in West Pharmaceutical in Q2 2021 and has held it in 13 quarters since.
  • XTX Topco's West Pharmaceutical position peaked at $2.44M in Q1 2025.
  • 830 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.